-------------------------------------------------------------------------
-------------------------------------------------------------------------
Weighted average number of common shares 38,017,065 37,787,825
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Basic loss per share (0.50) (0.79)
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Diluted loss per share (0.50) (0.79)
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Statements of Cash Flows (unaudited)
Years Ended September 30 2007 2006
$ $
OPERATING ACTIVITIES
Net loss and other comprehensive loss
for the year (18,975,299) (29,966,462)
Items not affecting cash
Gain on sale of surgical portfolio (10,028,913) -
Stock-based compensation expense 1,411,608 2,303,723
Interest capitalized on long-term debt 1,732,124 1,291,654
Amortization and write-off of consoles
at customers' premises 1,004,442 2,281,775
Amortization and write-off of property,
plant, and equipment 2,717,030 1,913,292
Amortization and write-off of
intellectual property 1,586,742 1,819,389
Amortization of deferred financing charges 382,877 26
'/>"/>
| SOURCE CryoCath Technologies Inc. Copyright©2007 PR Newswire. All rights reserved |